Ftse Mib
33.801,55
0,16%
DAX
17.902,26
-0,11%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.790,56
-0,77%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Forte Biosciences Inc (FBRX) Forte Biosciences Inc (FBRX) Notizie

Forte Biosciences Inc

FBRX
0,671
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/2/202422:16EDGAR2Form 8-K/A - Current report: [Amend]
14/2/202422:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202423:27EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202301:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202301:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:05EDGAR2Form 8-K - Current report
22/11/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/10/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202322:16EDGAR2Form 8-K/A - Current report: [Amend]
20/9/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202322:15EDGAR2Form 8-K - Current report
20/9/202322:05EDGAR2Form 8-K - Current report
14/9/202322:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
14/9/202316:50BWISS and Glass Lewis Recommend Forte Biosciences Stockholders..
11/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/9/202322:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/9/202322:31EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
06/9/202321:15BWConcerned Stockholders of Forte Biosciences and Its..
01/9/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/8/202323:29EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
31/8/202320:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/8/202323:57EDGAR2Form S-3 - Registration statement under Securities Act of..
25/8/202323:17EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
25/8/202316:10EDGAR2Form DEFC14A - Definitive proxy statement, contested..
25/8/202314:00BWConcerned Stockholders of Forte Biosciences File Definitive..
24/8/202312:15EDGAR2Form DEFC14A - Definitive proxy statement, contested..
23/8/202322:47EDGAR2Form SC 13D - General statement of acquisition of beneficial..
17/8/202315:30EDGAR2Form PRRN14A - Non-management revised preliminary proxy..
15/8/202323:15EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:20EDGAR2Form SC 13D/A - General statement of acquisition of..
04/8/202322:21EDGAR2Form 8-K - Current report
03/8/202322:31EDGAR2Form SC 13D/A - General statement of acquisition of..
03/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:28EDGAR2Form PREC14A - Preliminary proxy statements, contested..
01/8/202322:06EDGAR2Form 8-K - Current report
06/7/202322:08EDGAR2Form SC 13D/A - General statement of acquisition of..
Apertura: Min: Max:
Chiusura: 0,671

La tua Cronologia

NASDAQ
FBRX
Forte Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network